Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9526705
APP PUB NO 20160113882A1
SERIAL NO

14990406

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Lipidated glycosaminoglycan particles, prepared by reacting a glycosaminoglycan with at least one lipid to cross-link the carboxylic acid groups in the glycosaminoglycan with a primary amine in the lipid, are used to encapsulate drugs for use in the treatment of pathological conditions in an animal.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEL-AVIV UNIVERSITY FUTURE TECHNOLOGY DEVELOPMENT L P69978 TEL-AVIV

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Margalit, Rimona Givatayim, IL 22 253
Peer, Dan Qiryat Ono, IL 40 182

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 27, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00